Inputs: momentum, trendVelocity
Mixed signal: momentum 51/100, trend 57/100.
Prediction result · Ensemble engineUpdated 5:11 AM
ROIVRoivant Sciences Ltd. stock price outlook
$36.91-1.63% since prev closeNeutral
Roivant Sciences Ltd. (ROIV) is trading at $36.91, down 1.63% since the previous close and +1.15% over the past week. Price sits above its 50-day average by 0.72%, with price momentum at 51/100 and trend velocity at 57/100. Sentiment across 8 recent headlines reads net constructive at 62/100. Volatility risk is moderate (51/100) and the stock is 76% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
ROIV
Roivant Sciences Ltd.
$36.91-1.63%
LEANNEUTRAL / wait for cleaner tape
WHY
- Roivant Sciences Ltd. (ROIV) is trading at $36.91, down 1.63% since the previous close and +1.15% over the past week. Price sits above its 50-day average by 0.72%, with price momentum at 51/100 and trend velocity at 57/100. Sentiment across 8 recent headlines reads net constructive at 62/100. Volatility risk is moderate (51/100) and the stock is 76% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
- Bull input: No bullish case in the sources.
- Bear input: No bearish case in the sources.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · No edge
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
8 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment62/100
Price Momentum51/100
Trend Velocity57/100
Volatility Risk51/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Roivant Sciences Ltd. (ROIV) is trading at $36.91, down 1.63% since the previous close and +1.15% over the past week. Price sits above its 50-day average by 0.72%, with price momentum at 51/100 and trend velocity at 57/100. Sentiment across 8 recent headlines reads net constructive at 62/100. Volatility risk is moderate (51/100) and the stock is 76% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on ROIV
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgeNo edgeNeutral
Inputs: newsSentiment, dayChange
News positive but tape disagrees — divergence is itself a warning.
Inputs: unusualVolume, dayChange
Volume read 18/100 with price drift -1.6% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 51/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Mid-range positioning — no edge from range alone.
Inputs: newsSentiment, weekChange
Sentiment 62/100 vs week change 1.1% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 0.7% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 54 — neutral zone.
Inputs: momentum, dayChange, vsSma50
Momentum 51/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 62/100 and weekly change 1.1% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 18/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 51/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 76% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 62/100 and momentum 51/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance 0.7% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 54 does not show a rebound edge.
Why the ensemble agrees
- News positive but tape disagrees — divergence is itself a warning.
- Mixed signal: momentum 51/100, trend 57/100.
- Price within 0.7% of the 50d SMA — no clear structural read.
Bull Case
- No bullish case in the sources.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo Finance62
Roivant Sciences (ROIV) Stock Looks Fully Priced After A 393% Run
10/18/2026, 5:20:00 PM
Seeking Alpha55
Roivant Sciences: Brepocitinib And Roadmap Still Underpriced
11/13/2025, 4:28:00 AM
MSN67
ROIV stock nears record high: Moderna settlement drives Q4 profit, but pipeline catalysts keep retail interested
5/20/2026, 6:21:00 AM
Yahoo Finance60
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman
4/27/2026, 2:16:00 PM
Seeking Alpha65
Roivant Sciences: A Biotech Growth Play With Major Ambitions
12/4/2024, 5:30:00 AM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Market cap
- $26.66B
- 52-week range
- $42.5/$18.73
- Volume
- 4,574,578
- Avg volume
- 7,922,142
- Analyst 1-yr target
- $50.00
- Exchange
- NASDAQ-GS
Source: Nasdaq public quote data. Research only.
Insider trades
0 buys · 2 sells by ROIV insiders (SEC Form 4 filings)
- SELL Venker Eric President & Immunovant CEO · 2026-10-22$6.52M
- SELL Venker Eric President & Immunovant CEO · 2026-10-22$501K
Earnings Intelligence
Next
Nov 9, 2026
Estimate
$-0.52
Actual
$-0.45
- • Last report Aug 6, 2026 (Jun 2026): EPS $-0.45 vs $-0.45 expected, +0% surprise.
- • Beat estimates in 1 of the last 4 quarters.
- • Next report expected Nov 9, 2026, consensus EPS $-0.52 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • Markets can move against any signal regardless of the score.
- • Confirm liquidity, spreads, and your own thesis before acting.
ROIV questions
What is the MarketPicks AI signal for Roivant Sciences Ltd. stock (ROIV)?
As of Nov 2, 12:11 AM ET, the ensemble reads neutral on ROIV — no consensus — 16 of 16 bots holding, with 0 bull, 0 bear and 16 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest ROIV price on MarketPicks?
ROIV was $36.91 on the latest quote (Nov 2, 12:11 AM ET), -1.63% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for ROIV mean?
Scores run from 0 to 100, with 50 neutral. ROIV shows momentum 51/100, trend velocity 57/100 and volatility risk 51/100, with news sentiment at 62/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.